CCM
BMY.RT

Covington Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Covington Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,597
Closed -$20K – 893
2020
Q4 		$20K Sell
28,597
-1,750
-6% -$3.73K ﹤0.01% 584
2020
Q3 		$68K Sell
30,347
-538
-2% -$1.54K ﹤0.01% 419
2020
Q2 		$111K Hold
30,885
– – 0.01% 347
2020
Q1 		$117K Sell
30,885
-900
-3% -$2.96K 0.01% 317
2019
Q4 		$96K Buy
+31,785
New +$82.7K 0.01% 384

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Covington Capital Management's BMY.RT Position: Q1 2021 in Review

Covington Capital Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 28,597 shares — an estimated $20K sold.

Covington Capital Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $117K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Covington Capital Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Covington Capital Management sold 28,597 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $20K.
  • Covington Capital Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Covington Capital Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $117K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Covington Capital Management's 13F filing for Q1 2021, filed 14 May 2021.